Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

DIAGNOSIS

Abundant circulating lipids — a new opportunity for NSCLC detection?

Nature Reviews Clinical Oncology volume 19, pages 361–362 (2022)Cite this article

Non-small-cell lung cancer (NSCLC) is a growing public-health threat, with one of the highest mortality risks among non-communicable diseases. Now, researchers have developed a diagnostic tool for NSCLC by mass spectrometry of a targeted panel of lipids. Herein, we discuss key aspects that could facilitate the clinical implementation of this and similar tools in other fields of application.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Schmidt, D. R. et al. Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J. Clin. 71, 333–358 (2021).

    Article  Google Scholar 

  2. Yan, F., Zhao, H. & Zeng, Y. Lipidomics: a promising cancer biomarker. Clin. Transl. Med. 7, 21 (2018).

    Article  Google Scholar 

  3. Wang, G. et al. Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis. Sci. Transl. Med. 14, eabk2756 (2022).

    Article  CAS  Google Scholar 

  4. Lipidomics Standards Initiative Consortium. Lipidomics needs more standardization. Nat. Metab. 1, 745–747 (2019).

    Article  Google Scholar 

  5. O’Donnell, V. B. et al. Steps toward minimal reporting standards for lipidomics mass spectrometry in biomedical research publications. Circ. Genom. Precis. Med. 13, e003019 (2020).

    Article  Google Scholar 

  6. Burla, B. et al. MS-based lipidomics of human blood plasma: a community-initiated position paper to develop accepted guidelines. J. Lipid Res. 59, 2001–2017 (2018).

    Article  CAS  Google Scholar 

  7. Liebisch, G. et al. Update on LIPID MAPS classification, nomenclature, and shorthand notation for MS-derived lipid structures. J. Lipid Res. 61, 1539–1555 (2020).

    Article  CAS  Google Scholar 

  8. Tan, S. H. et al. Variability of the plasma lipidome and subclinical coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 42, 100–112 (2022).

    Article  CAS  Google Scholar 

  9. Köfeler, H. C. et al. Recommendations for good practice in MS-based lipidomics. J. Lipid Res. 62, 100138 (2021).

    Article  Google Scholar 

  10. Triebl, A. et al. Shared reference materials harmonize lipidomics across MS-based detection platforms and laboratories. J. Lipid Res. 61, 105–115 (2020).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry and Precision Medicine Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Markus R. Wenk

  2. Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore

    Hyungwon Choi

Authors
  1. Markus R. Wenk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hyungwon Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Markus R. Wenk or Hyungwon Choi.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wenk, M.R., Choi, H. Abundant circulating lipids — a new opportunity for NSCLC detection?. Nat Rev Clin Oncol 19, 361–362 (2022). https://doi.org/10.1038/s41571-022-00621-5

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41571-022-00621-5

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing